Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Army
Cantor Fitzgerald

Generated: April 21, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088482

« Back to Dashboard

NDA 088482 describes ANTABUSE, which is a drug marketed by Odyssey Pharms and Teva Womens and is included in three NDAs. It is available from two suppliers. Additional details are available on the ANTABUSE profile page.

The generic ingredient in ANTABUSE is disulfiram. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the disulfiram profile page.
Summary for 088482
Applicant:Odyssey Pharms
Formulation / Manufacturing:see details
Pharmacology for NDA: 088482
Medical Subject Heading (MeSH) Categories for 088482
Suppliers and Packaging for NDA: 088482
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ANTABUSE disulfiram TABLET;ORAL 088482 ANDA Teva Pharmaceuticals USA, Inc. 0093-5035 0093-5035-01 100 TABLET in 1 BOTTLE (0093-5035-01)
ANTABUSE disulfiram TABLET;ORAL 088482 ANDA Teva Women's Health, Inc. 51285-523 51285-523-02 100 TABLET in 1 BOTTLE (51285-523-02)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength250MG
Approval Date:Dec 8, 1983TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.